Insider Transactions in Q1 2024 at Prestige Consumer Healthcare Inc. (PBH)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2024
|
Mary Beth Fritz SVP Quality & Regulatory |
SELL
Open market or private sale
|
Direct |
172
-0.54%
|
$12,040
$70.42 P/Share
|
|
Mar 01
2024
|
Mary Beth Fritz SVP Quality & Regulatory |
BUY
Exercise of conversion of derivative security
|
Direct |
172
+0.53%
|
$7,396
$43.87 P/Share
|
|
Feb 28
2024
|
Mary Beth Fritz SVP Quality & Regulatory |
SELL
Open market or private sale
|
Direct |
662
-2.03%
|
$46,340
$70.28 P/Share
|
|
Feb 28
2024
|
Mary Beth Fritz SVP Quality & Regulatory |
BUY
Exercise of conversion of derivative security
|
Direct |
662
+1.99%
|
$28,466
$43.87 P/Share
|
|
Feb 27
2024
|
Mary Beth Fritz SVP Quality & Regulatory |
SELL
Open market or private sale
|
Direct |
1
-0.01%
|
$70
$70.0 P/Share
|
|
Feb 27
2024
|
Mary Beth Fritz SVP Quality & Regulatory |
BUY
Exercise of conversion of derivative security
|
Direct |
1
+0.01%
|
$57
$57.18 P/Share
|
|
Feb 26
2024
|
Mary Beth Fritz SVP Quality & Regulatory |
SELL
Open market or private sale
|
Direct |
9,677
-23.28%
|
$677,390
$70.44 P/Share
|
|
Feb 26
2024
|
Mary Beth Fritz SVP Quality & Regulatory |
BUY
Exercise of conversion of derivative security
|
Direct |
9,677
+18.9%
|
$416,111
$43.87 P/Share
|
|
Feb 23
2024
|
Mary Beth Fritz SVP Quality & Regulatory |
SELL
Open market or private sale
|
Direct |
23
-0.07%
|
$1,610
$70.0 P/Share
|
|
Feb 23
2024
|
Mary Beth Fritz SVP Quality & Regulatory |
BUY
Exercise of conversion of derivative security
|
Direct |
23
+0.07%
|
$989
$43.87 P/Share
|
|
Feb 15
2024
|
Adel Mekhail EVP, Marketing & Sales |
SELL
Open market or private sale
|
Direct |
15,549
-27.92%
|
$1,072,881
$69.15 P/Share
|
|
Feb 15
2024
|
Adel Mekhail EVP, Marketing & Sales |
BUY
Exercise of conversion of derivative security
|
Direct |
15,549
+21.32%
|
$544,215
$35.09 P/Share
|
|
Feb 14
2024
|
William P'Pool Officer |
SELL
Open market or private sale
|
Direct |
26,019
-34.28%
|
$1,743,273
$67.9 P/Share
|
|
Feb 14
2024
|
William P'Pool Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
26,019
+25.52%
|
$1,170,855
$45.02 P/Share
|
|
Feb 14
2024
|
Christine Sacco Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
30,019
-35.37%
|
$2,041,292
$68.25 P/Share
|
|
Feb 14
2024
|
Christine Sacco Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,788
+34.76%
|
$718,852
$29.46 P/Share
|
|
Feb 08
2024
|
Mary Beth Fritz SVP Quality & Regulatory |
SELL
Open market or private sale
|
Direct |
5,336
-25.09%
|
$368,184
$69.0 P/Share
|
|
Feb 08
2024
|
Mary Beth Fritz SVP Quality & Regulatory |
BUY
Exercise of conversion of derivative security
|
Direct |
5,336
+20.06%
|
$298,816
$56.11 P/Share
|